Quick Takeaways
- Lincoln Alternative Strategies LLC filed SCHEDULE 13G for XORTX Therapeutics Inc. Common Shares, no par value per share (XRTX).
- Disclosed ownership: 9.9%.
- Date of event: 23 Oct 2025.
Lincoln Alternative Strategies LLC - 23 Oct 2025 SCHEDULE 13G Report for XORTX Therapeutics Inc. Common Shares, no par value per share (XRTX)
- Filing Manager
- Lincoln Alternative Strategies LLC
- Reporting Manager
- Lincoln Alternative Strategies LLC
- Symbol
- XRTX
- Shares outstanding
- 5,782,525 shares
- Disclosed Ownership
- 572,470 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 27 Oct 2025, 16:29:23 UTC
- Date of event
- 23 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Lincoln Alternative Strategies LLC disclosed 9.9% ownership in XORTX Therapeutics Inc. Common Shares, no par value per share (XRTX) on 23 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Oct 2025, 16:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lincoln Alternative Strategies LLC | 9.9% | 572,470 | 572,470 | 0 | /s/ Stephen Temes | Stephen Temes/Managing Member |